Pharmaceutical Technology - May 2023

Pharmaceutical Technology - May 2023

Issue link: https://www.e-digitaleditions.com/i/1499609

Contents of this Issue

Navigation

Page 13 of 36

14 Pharmaceutical Technology ® Trends in Manufacturing eBook May 2023 PharmTech.com COCODESIGNTONG - STOCK.ADOBE.COM C leanroom or classified environmental infrastructures have been designed and constructed for decades (1) and can be either on-site framed epoxy coated gypsum wall (stick-built), on-site assembled mod- ular wall panels (modular), or off-site prefabricat- ed cleanroom units (podular), the last of which is a relatively recent addition. All of these cleanroom material and design modalities have benefits and limitations that require careful review when mak- ing decisions on which approach to use for con- structing current good manufacturing practice (CGMP) cleanroom infrastructure. Such decisions need to be made not only with the process appli- cation needs in mind, but also with the long-term perspective on future capability and capacity. This is especially important for multi-modal or multi-product processing streams and new thera- pies, which may not have a clearly defined process design or require process modifications along the way, and contract manufacturers, as their client base require process modalities change. In all cases, the need for f lexibility is real (2,3,4). However, f lexibility must be defined, as it is often used in genera l ter ms (5). Some cla im t hat sta n- dardization of cleanroom infrastructure designs, f a s ter del iver ies, a nd lower cos t of good s sold , w i l l i m p e d e o r p r e v e n t f l e x i b i l i t y. T h i s g e n- e r a l i z at ion m ay b e i n a cc u r ate, a s s m a l le r vol- umes requi re sma l ler process foot pr i nts, wh ich can be reconfigured within the available standard- ized space (6). Such spaces may be even more flexible if units can be scaled rapidly. To tr uly determine f lexibilit y, one needs to dis- sect the different f lexibility needs and the available solutions. Only then can an appropriate decision be made, which will not just satisf y the short-term re- quirements, but also show long-term benefits. The Quest for Cleanroom Flexibility Maik W. Jornitz Principal Consultant, BioProcess Resources LLC Sidney Backstrom VP Business Management, Blake Williams VP Operations, and Dennis Powers VP Business Development G-CON Manufacturing Inc. Contextualizing what type of flexibility is needed is paramount when considering cleanroom design.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2023 - Pharmaceutical Technology - May 2023